Literature DB >> 30405322

Geographic Variability of Active Ingredients in Spice as an Indicator of Mechanisms of Distribution and Manufacture Within Alaska.

Dakota W Emery1, Christopher R Iceman1,2, Sarah M Hayes1.   

Abstract

Designer drugs, like Spice, are synthetic psychoactive analogs of illegal substances with understudied health effects since they have traditionally been sold in packages labeled "not for human consumption" and the molecular structures can be specifically altered to circumvent legislation. Recent legislation has focused on regulating packaging and has reduced, but not eliminated, the distribution of Spice in Alaska. Legally obtained Spice samples from three geographic regions in Alaska were analyzed using liquid injection gas chromatography-mass spectrometry (GC-MS). Most (70%) of the samples contained illegal cannabinoids that have been regulated by the Drug Enforcement Agency and 47% contained multiple active ingredients. We hypothesized that the heterogeneity of the active ingredients between brands and across regions could be used to indicate small- or larger-scale manufacturing, and the results indicate multiple manufacturing scales. Evidence for small-scale manufacturing included inconsistent packaging, several of which contained similar active ingredient profiles in different brands purchased from a single store. Evidence for large-scale production was also found with some brands having consistent active ingredient profiles across regions. This study provides preliminary data for the geographic variability of active ingredients in Spice as an indicator of mechanisms of manufacture and distribution to inform legislators and law enforcement and help prioritizing resource allocation in an effort to quell Spice use in Alaska.

Entities:  

Year:  2018        PMID: 30405322      PMCID: PMC6217825          DOI: 10.22186/jyi.34.4.7-16

Source DB:  PubMed          Journal:  J Young Investig        ISSN: 1539-4026


  12 in total

Review 1.  Designer drugs: a medicinal chemistry perspective.

Authors:  F Ivy Carroll; Anita H Lewin; S Wayne Mascarella; Herbert H Seltzman; P Anantha Reddy
Journal:  Ann N Y Acad Sci       Date:  2011-11-17       Impact factor: 5.691

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

3.  The emergence and analysis of synthetic cannabinoids.

Authors:  Simon Hudson; John Ramsey
Journal:  Drug Test Anal       Date:  2011-02-21       Impact factor: 3.345

4.  Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016.

Authors:  Yuri P Springer; Roy Gerona; Erich Scheunemann; Sarah L Shafer; Thomas Lin; Samuel D Banister; Michael P Cooper; Louisa J Castrodale; Michael Levy; Jay C Butler; Joseph B McLaughlin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-14       Impact factor: 17.586

5.  Tracing geographic and temporal trafficking patterns for marijuana in Alaska using stable isotopes (C, N, O and H).

Authors:  Amanda L Booth; Matthew J Wooller; Timothy Howe; Norma Haubenstock
Journal:  Forensic Sci Int       Date:  2010-05-21       Impact factor: 2.395

6.  DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.

Authors:  Jun Ogata; Nahoko Uchiyama; Ruri Kikura-Hanajiri; Yukihiro Goda
Journal:  Forensic Sci Int       Date:  2012-10-23       Impact factor: 2.395

7.  Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.

Authors:  Amelia M Kasper; Alison D Ridpath; Justin K Arnold; Kevin Chatham-Stephens; Melissa Morrison; Olaniyi Olayinka; Christina Parker; Robert Galli; Robert Cox; Nykiconia Preacely; Jannifer Anderson; Patrick B Kyle; Roy Gerona; Colleen Martin; Josh Schier; Amy Wolkin; Thomas Dobbs
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-10-09       Impact factor: 17.586

8.  Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-12-13       Impact factor: 17.586

9.  Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.

Authors:  Royal Law; Josh Schier; Colleen Martin; Arthur Chang; Amy Wolkin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-12       Impact factor: 17.586

10.  Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-15       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.